Steady state pharmacokinetic profile of indomethacin in elderly patients and young volunteers.
The steady-state pharmacokinetic profile of indomethacin was examined in twelve healthy volunteers (4 m, 8 f; 20-34 y) and in 12 elderly subjects (7 m, 5 f; 70-88 y). Two formulations of indomethacin were examined, providing duplicate data for each subject group. The subjects received each formulation of indomethacin (25 mg tid) for 6 days in a single blind crossover fashion. On day 7, after an overnight fast, a final 25 mg dose of indomethacin was given and plasma concentrations measured over the following 12 h. Kinetic parameters Cpmin, Tmax and AUC (0-12 h) were determined. There were no differences in the pharmacokinetic parameters between young and elderly subjects or between data for the two formulations of indomethacin. AUC values (micrograms.ml-1.h), for example, for the two formulations in the young subjects were 5.85 and 6.85 while the values for the elderly subjects were 6.55 and 6.50 respectively. When each treatment period was considered independently there was a significant difference between young and elderly subjects with regard to compliance. The rates of non compliance (over and under compliance) using a capsule count technique were, however, low with a mean maximum value of 5.8% being recorded for the elderly subjects.
McElnay
J C
JC
School of Pharmacy, Queen's University of Belfast.
Passmore
A P
AP
Crawford
V L
VL
McConnell
J G
JG
Taylor
I C
IC
Walker
F S
FS
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002626:Chemistry, Pharmaceutical; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D010003:Osteoarthritis / Q000378:metabolism; D010349:Patient Compliance; D016037:Single-Blind Method
D007213:Indomethacin